Therapeutic Target Identification Science. 2021 Mar5;371(6533):eabc8697. Targeting a neoantigen derived from a common TP53 mutation. Valid-NEO Science Immunology. 2021 Mar 1;6(57):eabd5515. Bispecific antibodies targeting mutant RAS neoantigens.Valid-NEO Transformative discoveryTissue Omics Testing automationTissue Omics Accuracy & precisionTissue Omics Drugs & chemicalsTissue Omics Biomarker and Liquid Biopsy Testing proceduresLiquid Omics Laboratory analysisLiquid Omics Genetic testingLiquid Omics Genetic dataLiquid Omics Digital testingLiquid Omics Drug consultingLiquid Omics Innovations in pharmacyStudy AI and pharmaciesStudy